Fermenta Biotech Documents
Documents
0
Ticker
506414.BO
ISIN
INE225B01021
Fermenta Biotech SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Fermenta Biotech Documents 2026
This page contains all official documents and SEC filings for Fermenta Biotech stock (506414.BO, ISIN: INE225B01021). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Fermenta Biotech's regulatory filings.
Fermenta Biotech Stock analysis
Fermenta Biotech Fermenta Biotech Ltd is a pharmaceutical company headquartered in Thane, India, listed on the stock exchange on 4 January 1990. With a workforce of 550 employees, the firm operates primarily in the manufacturing and supply of Vitamin D3 and other bulk drugs. Its Chemicals and Bulk Drug segment produces enzymes and specialized technologies for the biopharmaceutical life cycle, serving industries such as pharmaceuticals, animal feed, and food fortification. Additionally, the company offers nutritional ingredients like fish oil-derived cholesterol and natural astaxanthin. The Property segment complements these operations by managing the renting and sale of real estate assets.